US Patent 8,309,527
United States Patent and Trademark Office
University of Iowa Research Foundation (Iowa City, IA, US) ; The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, DC, US) ; Coley Pharmaceutical Group, Inc. (New York, NY, US)
Oligonucleotides containing unthylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response in a subject are disclosed. Also disclosed are therapies for treating diseases associated with immune system activation that are initiated by unthylated CpG dinucleotides in a subject comprising administering to the subject oligonucleotides that do not contain unmethylated CpG sequences (i.e. methylated CpG sequences or no CpG sequence) to outcompete unmethylated CpG nucleic acids for binding. Further disclosed are methylated CpG containing dinucleotides for use antisense therapies or as in vivo hybridization probes, and immunoinhibitory oligonucleotides for use as antiviral therapeutics.
Krieg, Arthur M.; Klinman, Dennis; and Steinberg, Alfred D. Immunomodulatory oligonucleotides. US Patent 8,309,527 filed February 26, 2004 and issued November 13, 2012. https://ir.uiowa.edu/patents/586